Pfizer (PFE) Buildings (2009 - 2013)

Pfizer (PFE) has 5 years of Buildings data on file, last reported at $10.1 billion in Q4 2013.

• Buildings for Q4 2013 came in at $10.1 billion, down 5.52% year-over-year; the trailing twelve-month figure through Dec 2013 was $10.1 billion (down 5.52% YoY), and the FY2013 annual result was $10.1 billion, down 5.52% from the prior year.
• Buildings fell to $10.1 billion in Q4 2013 per PFE's latest filing, from $10.6 billion in the prior quarter.
• Over five years, Buildings peaked at $14.2 billion in Q4 2009 and troughed at $10.1 billion in Q4 2013.
• A 5-year average of $12.0 billion and a median of $12.1 billion in 2011 frame the typical range for Buildings.
• The sharpest annual moves came in 2012 and 2013: Buildings fell 11.96% in 2012, then retreated 5.52% in 2013.
• A 5-year view of Buildings shows it stood at $14.2 billion in 2009, then fell by 6.95% to $13.2 billion in 2010, then slipped by 8.42% to $12.1 billion in 2011, then slipped by 11.96% to $10.6 billion in 2012, then declined by 5.52% to $10.1 billion in 2013.
• Business Quant data shows PFE's Buildings at $10.1 billion in Q4 2013, $10.6 billion in Q4 2012, and $12.1 billion in Q4 2011.